📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Amerita

1.1 - Company Overview

Amerita Logo

Amerita

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty infusion services focused on delivering complex pharmaceutical products and clinical services.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Amerita

Plexxikon Logo

Plexxikon

HQ: United States Website
  • Description: Provider of small molecule pharmaceuticals focused on discovering and developing therapies for human diseases. Portfolio includes Zelboraf for BRAF V600E–mutant skin cancer, Turalio for tenosynovial giant cell tumor (TGCT), and personalized medicines. Pipeline candidates include PLX204 for diabetes, PLX4032 for melanoma and colorectal cancer, and PLX5568 kinase inhibitors for pain and polycystic kidney disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Plexxikon company profile →
Valera Pharmaceuticals Logo

Valera Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty pharmaceutical services concentrating on development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Valera Pharmaceuticals company profile →
Endacea Logo

Endacea

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies targeting the A1 adenosine receptor, including L-97-1, an intravenous A1 adenosine receptor antagonist for sepsis and acute renal failure, and a mutant plasmid cDNA for cancer administered as an intratumor injection. Both programs are in the preclinical stage.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Endacea company profile →
Pieris Pharmaceuticals Logo

Pieris Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical-stage immuno-oncology biotechnology programs, including 4-1BB bispecific programs developed with Pfizer, Servier, and Boston Pharmaceuticals, and potential future partnership royalties from sales of approved partnered immuno-oncology assets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pieris Pharmaceuticals company profile →
TiGenix Logo

TiGenix

HQ: Belgium Website
  • Description: Provider of innovative local regenerative medicine treatments for damaged and osteoarthritic joints, focusing on research and development of durable therapies validated through controlled clinical studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TiGenix company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Amerita

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Amerita

2.2 - Growth funds investing in similar companies to Amerita

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Amerita

4.2 - Public trading comparable groups for Amerita

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Amerita

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Amerita

What does Amerita do?

Amerita is a provider of specialty infusion services focused on delivering complex pharmaceutical products and clinical services.

Who are Amerita's competitors?

Amerita's competitors and similar companies include Plexxikon, Valera Pharmaceuticals, Endacea, Pieris Pharmaceuticals, and TiGenix.

Where is Amerita headquartered?

Amerita is headquartered in United States.

How many employees does Amerita have?

Amerita has 1,000 employees 🔒.

When was Amerita founded?

Amerita was founded in 2010 🔒.

What sector and industry vertical is Amerita in?

Amerita is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Amerita

Who are the top strategic acquirers in Amerita's sector and industry

Top strategic M&A buyers and acquirers in Amerita's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Amerita?

Top strategic M&A buyers groups and sectors for Amerita include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Amerita's sector and industry vertical

Which are the top PE firms investing in Amerita's sector and industry vertical?

Top PE firms investing in Amerita's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Amerita's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Amerita's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Amerita's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Amerita include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Amerita's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Amerita?

The key public trading comparables and valuation benchmarks for Amerita include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Amerita for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Amerita with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Amerita's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Amerita with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Amerita's' sector and industry vertical?

Access recent funding rounds and capital raises in Amerita's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Amerita